Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Cash & Current Investments (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Cash & Current Investments for 16 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 109.69% to $8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.6 million through Dec 2025, up 109.69% year-over-year, with the annual reading at $8.6 million for FY2025, 109.69% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $8.6 million at Harvard Bioscience, up from $6.8 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $8.6 million in Q4 2025, with the low at $3.8 million in Q1 2023.
  • Average Cash & Current Investments over 5 years is $5.4 million, with a median of $5.2 million recorded in 2022.
  • The sharpest move saw Cash & Current Investments soared 137.24% in 2021, then plummeted 42.36% in 2022.
  • Over 5 years, Cash & Current Investments stood at $7.8 million in 2021, then tumbled by 42.36% to $4.5 million in 2022, then fell by 4.99% to $4.3 million in 2023, then dropped by 4.09% to $4.1 million in 2024, then soared by 109.69% to $8.6 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $8.6 million, $6.8 million, and $7.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.